Samsung Biologics Co.,Ltd. (207940.KS) KSC

1,367,000.00

-10000(-0.73%)

Updated at June 02 03:30PM

Currency In KRW

Samsung Biologics Co.,Ltd.

Address

300, Songdo Bio-daero

Incheon, 21987

Korea (the Republic of)

Phone

82 3 2455 3114

Website

https://samsungbiologics.com

Sector

Healthcare

Industry

Biotechnology

Employees

4770

First IPO Date

November 11, 2016

Key Executives

Name	Title	Pay	Year Born
John Chongbo Rim	Chief Executive Officer, President & Chairman of Board	7.9B	1961
James J. Choi	Executive Vice President, Head of CDO Development Center & Head of Sales Center	569M	1967
Kun Lo	Executive Vice President, Head of EPCV Center & Director	2.2B	1963
Heekyun Lim	Vice President & Head of Business Consulting Team	0	1975
Kevin Sharp	EVP, Head of Sales & Operations Department	0	N/A
Kyuho Lee	Executive Vice President, Head of People Center, & Chief Human Resource Officer	0	N/A
Seungho Ryu	EVP, CFO, Head of Business Support Center & Director	0	1968
Heejeong Kim	VP & Head of DS Department	0	N/A
Sojeong Lee	Vice President & Head of Regulatory Affairs	0	N/A
Pierre Catignol	Executive Vice President & Head of Operation Center	0	1968

Description

Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.